Other inflammatory cytokines with demonstrated reduction after ADT in prostate cancer patients include IL-1β, IL-2, tumor necrosis factor (TNF)-α, and interferon (IFN)-γ [49,50]. This evidence concerns the gene IL2 and prostate carcinoma.